Multiplex allele-specific PCRs detecting katG codon 315 and mabA (bp ؊15) mutations could specifically identify 77.5% of isoniazid-resistant Mycobacterium tuberculosis strains in the South China region. One clinical isolate harboring InhA Ile194Thr was characterized to show strong association with isoniazid resistance in Mycobacterium tuberculosis.
Tuberculosis (TB) remains a public health issue in many parts of the world (20) . The situation is further complicated by the emergence of multidrug-resistant TB (18) . Multidrug-resistant TB is recognized as infection with Mycobacterium tuberculosis resistant to at least isoniazid (INH) and rifampin. Mutations in dispersed gene loci including katG (catalaseperoxidase), the promoter region of ahpC (alkyl hydroperoxidase), inhA (enoyl-acyl reductase), kasA (␤-ketoacyl ACP synthase), mabA (3-ketoacyl reductase), and ndh (NADH dehydrogenase) have been found to be associated with INH resistance (2, 4, 7, (10) (11) 22) . Our previous study using PCR with restriction fragment length polymorphism (PCR-RFLP) to detect the KatG amino acid substitution Ser315Thr successfully identified 51% of INH R M. tuberculosis strains among 375 clinical isolates from the South China region (9) . In the present study, a multiplex allele-specific PCR (MAS-PCR) was used to detect mutations in mabA (bp Ϫ15) of our clinical isolates. The potential use of mabA and katG MAS-PCRs (12) for rapid diagnosis of INH R M. tuberculosis was evaluated. INH R isolates negative for katG 315 alterations were subsequently subjected to DNA sequencing of various gene loci associated with INH resistance. A novel mutation in inhA was characterized to elucidate non-katG-related resistance mechanisms.
Three hundred seventy-five M. tuberculosis isolates collected from patients suffering from tuberculosis in Hong Kong and the South China region between 1999 and 2002 were tested for susceptibility to the antimycobacterial agent INH by using 7H10 medium containing INH at 0.2 or 1.0 g/ml (9, 13). Mycobacterial DNA was extracted as described previously (19) .
The KatG MAS-PCR protocol was essentially adopted from the work of Mokrousov et al. (12) . A mutation at codon 315 would yield an amplicon of 435 bp (Fig. 1a) , and wild-type katG would yield a smaller amplicon of 293 bp. For mabA MAS-PCR, 30 pmol of each of the designed primers MabAϪ115F (5Ј-ACAAACGTCACGAGCGTAACC-3Ј), MabAϩ4R (5Ј-TCACCCCGAGAHCCTATCG-3Ј), and MabAϩ336R (5Ј-GTTGGCGTTGATGACCTTCTC-3Ј) was used with the same cycling conditions as those for katG MAS-PCR. For wild-type strains, two fragments of 451 bp and 119 bp were amplified, while a single 451-bp fragment was amplified for mutants (Fig. 1b) . Performance of mabA MAS-PCR was verified by DNA sequencing of 100 randomly selected isolates (50 susceptible and 50 resistant) using an ABI3700 genetic sequencer (Applied Biosystems) as described previously (21) . Sequencing primers used for different gene loci are listed in Table 1 .
Both wild-type and Ile194Thr InhA proteins were expressed for kinetic analysis using the pET-15b expression vector (Novagen, Madison, Wis.) and Escherichia coli BL21(DE3) as the host. All kinetic reactions were carried out in 30 mM piperazine-N,NЈ-bis(2-ethanesulfonic acid) (PIPES) buffer, pH 6.8, using 2-trans-hexadecenyl coenzyme A as a substrate, at 25°C (3, 14) . Following NADH oxidation at A 340 , steady-state K m values for NADH were determined with variable concentrations of NADH at fixed saturating concentrations of the substrate. The experiment was repeated with three separate preparations of purified recombinant proteins. Data were fitted to a Michaelis-Menten equation and plotted in Lineweaver-Burk reciprocal form with GraphPad Prism v4.0 software to generate estimates of K m and V max values.
Among 375 clinical isolates, 371 were successfully amplified by katG and mabA MAS-PCR assays. Four INH R isolates previously identified as catalase negative (9) were positive only by mabA MAS-PCR. Fifty-two of the 102 resistant isolates exhibited katG codon 315 alteration (Fig. 2a) . The remaining 50 resistant isolates, as well as the 273 susceptible isolates, showed no mutation in katG codon 315. The findings completely agree with our previous antimycobacterial susceptibility testing, PCR-RFLP, and DNA sequencing results (9) . With mabA MAS-PCR, 32 of 102 resistant isolates were identified as having a mutation in mabA bp Ϫ15 (Fig. 2b) . The remaining 70 resistant isolates and the 273 susceptible isolates exhibited no mutation in the corresponding region. The results also agree with DNA sequencing results of 100 randomly selected isolates (50 resistant and 50 susceptible). Further analysis revealed that 79 (77.5%) resistant isolates carried one or both of the mutations with 100% specificity. 5, 8) .
The MIC of INH for the last strain was Ͼ1.0 g/ml, and there was a point mutation at bp 581 of inhA (GenBank accession no. AF06077) causing the amino acid substitution Ile194Thr (ATC3ACC). Compared with wild-type InhA of H37Rv (ATCC 27294), purified protein with Ile194Thr showed a 5-fold increase in K m without a significant increase (1.3-fold only) in V max (Table 2 and Fig. 3) . The high K m suggested that under cellular concentrations of NADH, Ile194Thr affects the binding of NADH to the enzyme and decreases the rate of reaction. Unless a very high concentration of NADH is available, which is unlikely, since the cellular concentration of NADH is less than 10 M (14), the reaction rate cannot be raised to normal wild-type levels. This finding is also consistent with previous X-ray crystallography data (http://au.expasy.org) showing that isoleucine 194 lies within the binding cleft of the enzyme and in close proximity with the oxygen atom of NADH (16) . It is likely that isoleucine 194 participates in hydrogen bonding with the docked NADH. Recently, molecular dynamics simulations also showed Ile194 as 1 of the 10 most important amino acid residues making conserved H bonds with NADH cofactor in wild-type InhA protein (17) . It is quite 
